» Articles » PMID: 16651401

Lysophosphatidic Acid Binds to and Activates GPR92, a G Protein-coupled Receptor Highly Expressed in Gastrointestinal Lymphocytes

Overview
Specialty Pharmacology
Date 2006 May 3
PMID 16651401
Citations 106
Authors
Affiliations
Soon will be listed here.
Abstract

Here, the ligand binding, activation, and tissue distribution of the orphan G protein-coupled receptor (GPCR) GPR92 were studied. GPR92 binds and is activated by compounds based on the lysophosphatidic acid (LPA) backbone. The binding of LPA to GPR92 was of high affinity (K(D) = 6.4 +/- 0.9 nM) and led to an increase in both phosphoinositide hydrolysis and cAMP production. GPR92 is atypical in that it has a low sequence homology with the classic LPA(1-3) receptors (21-22%). Expression of GPR92 is mainly found in heart, placenta, spleen, brain, lung, and gut. Notably, GPR92 is highly expressed in the lymphocyte compartment of the gastrointestinal tract. It is the most abundant GPCR activated by LPA found in the small intestinal intraepithelial CD8+ cytotoxic T cells.

Citing Articles

GPCRs: emerging targets for novel T cell immune checkpoint therapy.

Dickinson K, Yee E, Vigil I, Schulick R, Zhu Y Cancer Immunol Immunother. 2024; 73(12):253.

PMID: 39358616 PMC: 11447192. DOI: 10.1007/s00262-024-03801-7.


The Role of Lysophospholipid Metabolites LPC and LPA in the Pathogenesis of Chronic Obstructive Pulmonary Disease.

Zhou Q, Chen Y, Liang Y, Sun Y Metabolites. 2024; 14(6).

PMID: 38921452 PMC: 11205356. DOI: 10.3390/metabo14060317.


LPA-Dependent signaling regulates regeneration of the intestinal epithelium following irradiation.

McConnell B, Liang Z, Xu C, Han Y, Yun C Am J Physiol Gastrointest Liver Physiol. 2024; 326(6):G631-G642.

PMID: 38593468 PMC: 11376986. DOI: 10.1152/ajpgi.00269.2023.


pharmacological characterization of standard and new lysophosphatidic acid receptor antagonists using dynamic mass redistribution assay.

Ruzza C, Argentieri M, Ferrari F, Armani E, Trevisani M, Marchini G Front Pharmacol. 2023; 14:1267414.

PMID: 38035009 PMC: 10682101. DOI: 10.3389/fphar.2023.1267414.


A dual role of lysophosphatidic acid type 2 receptor (LPAR2) in nonsteroidal anti-inflammatory drug-induced mouse enteropathy.

Hutka B, Varallyay A, Laszlo S, Toth A, Scheich B, Paku S Acta Pharmacol Sin. 2023; 45(2):339-353.

PMID: 37816857 PMC: 10789874. DOI: 10.1038/s41401-023-01175-7.